Nathan Connell Reflects on the Impact of COCs on VWD Patients Compared to Healthy People
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
”Navigating a bleeding disorder like von Willebrand Disease (VWD) can be challenging, especially when heavy menstrual bleeding is a major symptom.
Many patients use combination oral contraceptives (COCs) to manage this, but a key question has always been: “Does this affect my diagnosis?”
A recent scoping review and meta-analysis of 27 studies in Haemophilia Journal from Eve Justason, Anna Ishchuk, Benjamin P. Ott, Sophie Gibson, and Paula D. James sought to answer just that.
The researchers found that COC use did not significantly change von Willebrand factor (VWF) or factor VIII (FVIII) levels.
The meta-analysis of VWF% and FVIII% revealed no statistically significant difference between participants with and without COC use (VWF% Estimate: 2.62, p=0.4033; FVIII% Estimate: 2.99, p=0.4552).
These are important data for anyone who is faced with diagnosing VWD.
It provides crucial clarity by validating that COCs do not appear to interfere with the accurate diagnosis of VWD.
This is a vital piece of the puzzle for improving diagnostic certainty and ensuring appropriate management for individuals with bleeding disorders.”
Read the full article in Haemophilia Journal.
Article: Determining the Impact of Combination Oral Contraceptives on Von Willebrand Factor and Factor VIII in Healthy Patients and Patients With Von Willebrand Disease: A Scoping Review and Meta-Analysis
Authors: Eve Justason, Anna M. Ishchuk, Benjamin P. Ott, M. E. Sophie Gibson, Paula D. James
Stay updated on all scientific advances in the field of bleeding disorders with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers